Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication made for completion of annual report FY 2025-26 dispatch to shareholders
Fischer Medical Ventures Limited has informed the Exchange about Presentation
Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication for Advance Intimation of dispatch of Annual Report 2026 through electronic mode
Fischer Medical Ventures will host a virtual one-to-one meeting with institutional investors on Monday, September 7, 2026, at 12:30 PM (IST). Discussions will focus on the company's business and general information already in the public domain.
Fischer Medical Ventures' board appointed David Yeow as an Independent Director, leading to Audit Committee changes. The 33rd Annual General Meeting (AGM) is scheduled for September 29th via video conference. Share transfer books close Sept 23-29.
